CCXYX | FCAVX | CCXYX / FCAVX | |
Total Expense Ratio | 0.48 | 0.52 | 92% |
Annual Report Gross Expense Ratio | 0.53 | 0.52 | 102% |
Fund Existence | 8 years | 24 years | - |
Gain YTD | -2.573 | -2.263 | 114% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 309M | 12.5B | 2% |
Annual Yield % from dividends | 3.94 | 3.86 | 102% |
Returns for 1 year | -1.17 | -1.04 | 113% |
Returns for 3 years | 9.74 | 6.35 | 153% |
Returns for 5 years | -1.14 | -3.55 | 32% |
Returns for 10 years | N/A | 3.14 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHSAX | 61.68 | -0.30 | -0.48% |
BlackRock Health Sciences Opps Inv A | |||
GBCAX | 17.35 | -0.20 | -1.14% |
Gabelli Dividend Growth A | |||
TEMSX | 8.57 | -0.14 | -1.61% |
Nuveen Emerging Markets Eq Retiremt | |||
TRDFX | 11.80 | -0.20 | -1.67% |
Steward Values Enhanced SmMidCapA | |||
GLVAX | 82.36 | -1.53 | -1.82% |
Invesco Global Focus A |